Alliance for Regenerative Medicine Announces Agenda for Clinical Outlooks for Regenerative Medicine Meeting
(firmenpresse) - WASHINGTON, DC -- (Marketwire) -- 06/05/12 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced the full agenda for the Clinical Outlooks for Regenerative Medicine meeting. The event will take place on June 19, 2012 at The Starr Center, Schepens Eye Research Institute, 185 Cambridge Street, Boston, MA.
As regenerative medicine and cell therapy products advance further in clinical studies toward gaining approval, it is important to understand how these products will be administered and how they will perform clinically. This meeting, which was organized jointly by ARM and the Harvard Stem Cell Institute, will explore the clinical status for certain key disease areas from the perspective of clinicians, patient groups and leading regenerative medicine companies. The full agenda is as follows:
Global View of Regenerative Medicine in the Clinical Setting
, Harvard Stem Cell Institute
, ARM; Athersys, Inc.
Moderator:
, California Institute for Regenerative Medicine
Speakers:
, Advanced Cell Technology
, University College London Institute of Child Health
, Schepens Eye Research Institute; Harvard Medical School
Moderator:
, JDRF
Speakers:
, Joslin Diabetes Center; Harvard Medical School
Schulze Diabetes Institute; University of Minnesota
ViaCyte
, BetaLogics, a division of Janssen Pharmaceutical Companies of Johnson & Johnson
, HHMI/Children's Hospital Boston, Harvard Medical School, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Stem Cell Institute and Manton Center for Orphan Disease Research
Moderator:
Parkinson's Action Network
Speakers:
, Massachusetts General Hospital; Harvard Medical School
, StemCells, Inc.
, University of Rochester Medical Center
, InVivo Therapeutics
Moderator:
, Harvard Medical School; Harvard Stem Cell Institute; Brigham and Women's Hospital
Speakers:
, Summa Cardiovascular Institute; Summa Akron City Hospital; Northeast Ohio Medical University
, NeoStem
, Mesoblast
Moderator:
, Health Advances
Speakers:
, Organogenesis
, Advanced BioHealing, a Shire Company
, Tufts University School of Medicine
, University of Miami School of Medicine
To learn more and to register for the conference, please visit . Complimentary registration is available for credentialed members of the media and HSCI affiliated clinicians and researchers.
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization that promotes legislative, regulatory, reimbursement and financing initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, and provides services to support the growth of its member companies and organizations. Prior to the formation of ARM, there was no advocacy organization operating in Washington, DC to specifically represent the interests of regenerative medicine companies, research institutions, investors, and patient groups supporting more rapid adoption of technologies in our field. To learn more about ARM or to become a member, visit .
The Harvard Stem Cell Institute (HSCI) is a scientific collaborative established to investigate the complex biology and therapeutic potential of stem cells. With over 200 faculty members at Harvard and its 11 affiliated hospitals, HSCI supports cutting-edge science through sponsoring research projects, operating core facilities, managing events and offering training opportunities.
Media Contact:
Michelle Linn
Linnden Communications
Phone: 508-362-3087
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.06.2012 - 10:10 Uhr
Sprache: Deutsch
News-ID 1121219
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
WASHINGTON, DC
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 112 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Alliance for Regenerative Medicine Announces Agenda for Clinical Outlooks for Regenerative Medicine Meeting
"
steht unter der journalistisch-redaktionellen Verantwortung von
The Alliance for Regenerative Medicine (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
